Royal Bank of Canada
KRRO icon

Royal Bank of Canada’s Korro Bio KRRO Stock Holding History

Royal Bank of Canada’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Sell
104
-120
-54% -$1.32K ﹤0.01% 6889
2025
Q4 		$2K Sell
224
-5,768
-96% -$135K ﹤0.01% 6908
2025
Q3 		$287K Sell
5,992
-613
-9% -$13.6K ﹤0.01% 4859
2025
Q2 		$82K Buy
6,605
+508
+8% +$7.32K ﹤0.01% 5717
2025
Q1 		$106K Sell
6,097
-1,623
-21% -$48.1K ﹤0.01% 5176
2024
Q4 		$294K Buy
7,720
+7,042
+1,039% +$362K ﹤0.01% 4497
2024
Q3 		$23K Buy
678
+3
+0.4% +$126 ﹤0.01% 6048
2024
Q2 		$23K Buy
675
+578
+596% +$31.9K ﹤0.01% 6013
2024
Q1 		$9K Sell
97
-821
-89% -$44.8K ﹤0.01% 6239
2023
Q4 		$44K Buy
918
+894
+3,725% +$29.5K ﹤0.01% 6049
2023
Q3 		$0 Sell
24
-9
-27% -$226 ﹤0.01% 7332
2023
Q2 		$1K Buy
33
+21
+175% +$407 ﹤0.01% 7022
2023
Q1 		$0 Buy
+12
New +$1.37K ﹤0.01% 7275
2022
Q4 		– Sell
-12
Closed -$1.24K – 7483
2022
Q3 		$1K Sell
12
-15
-56% -$1.52K ﹤0.01% 7209
2022
Q2 		$3K Sell
27
-28
-51% -$1.89K ﹤0.01% 6835
2022
Q1 		$6K Sell
55
-91
-62% -$17.4K ﹤0.01% 7182
2021
Q4 		$38K Buy
146
+73
+100% +$22.2K ﹤0.01% 6525
2021
Q3 		$26K Buy
73
+14
+24% +$5.51K ﹤0.01% 6550
2021
Q2 		$29K Buy
59
+9
+18% +$4.39K ﹤0.01% 6363
2021
Q1 		$24K Sell
50
-131
-72% -$255K ﹤0.01% 6326
2020
Q4 		$319K Buy
181
+163
+906% +$215K ﹤0.01% 4495
2020
Q3 		$17K Hold
18
– – ﹤0.01% 5756
2020
Q2 		$21K Buy
18
+2
+13% +$1.81K ﹤0.01% 5572
2020
Q1 		$14K Buy
16
+15
+1,500% +$16.2K ﹤0.01% 5701
2019
Q4 		$1K Buy
+1
New +$778 ﹤0.01% 6663

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Royal Bank of Canada's KRRO Position: Q1 2026 in Review

Royal Bank of Canada reduced its Korro Bio (KRRO) stake by 54% in Q1 2026, selling an estimated $1.32K and leaving 104 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6889.

Royal Bank of Canada first reported a position in KRRO in Q4 2019 and has held it in 25 quarters since. The position peaked at $319K in Q4 2020. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Royal Bank of Canada held 104 shares of Korro Bio worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 120 Korro Bio shares in Q1 2026, an estimated $1.32K.
  • Korro Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6889 holding.
  • Royal Bank of Canada first reported a position in Korro Bio in Q4 2019 and has held it in 25 quarters since.
  • Royal Bank of Canada's Korro Bio position peaked at $319K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.